Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
PharmAbcine announces the execution of a Material Cooperative Research and Development Agreement (MCRADA) with the NIH to evaluate the efficacy of PMC-403 to treat SCLS 2020-08-18 21:00
Global Cord Blood Corporation to Report First Quarter Fiscal 2021 Financial Results 2020-08-18 19:00
Koichiro Matsumoto Appointed President/CEO of Bushu Pharmaceuticals Ltd. 2020-08-18 14:00
China Biologic Reports Financial Results for the Second Quarter of 2020 2020-08-18 04:30
I-Mab Announces First Patient Dosed in Phase 1b Study of Plonmarlimab in Rheumatoid Arthritis in China 2020-08-17 20:00
CARsgen Announces the Publication of a Novel CAR-T Technology that Improves the Efficacy of CAR-T cells Against Solid Tumors without Requiring Preconditioned Lymphodepletion 2020-08-17 18:00
China Pharma Holdings, Inc. Reports Second Quarter 2020 Financial Results 2020-08-14 18:30
Bushu Pharmaceuticals Announces Major Expansion Program 2020-08-14 14:00
Hankyung.com's introduces: "Seoul Made" PPE kits, targeting US Market 2020-08-14 08:00
WuXi AppTec Achieved Strong Growth in First-Half of 2020 with China Sites Resuming Full Operations 2020-08-13 16:49
United Imaging, Debuting at AHRA as a Gold Sponsor, Announces FDA Clearance of Its Latest Deep Learning Reconstruction Technology, uAI HYPER DLR 2020-08-12 00:00
CPHI to Hold Second Quarter 2020 Earnings Conference Call On Friday August 14, 2020 at 8:30 a.m. ET 2020-08-11 22:10
New Study Proves Asclepius Meditec's Hydrogen Oxygen Generator Helps Improve COVID-19 Disease Severity and Dyspnea 2020-08-10 21:00
Fapon 2nd COVID-19 Donation, 100 Million Anti-SARS-CoV-2 Fully Human RBD IgM & IgG QC Test Materials 2020-08-10 20:00
China Biologic Products to Report Second Quarter 2020 Financial Results 2020-08-10 20:00
Co-Diagnostics, Inc. Logix Smart™ COVID-19 Test Authorized for Use in Australia 2020-08-07 18:30
CMAB Appoints Ms. Maggie Chen as Chief Financial Officer 2020-08-07 08:00
ImmVira and Shanghai Pharma Announce Clinical Collaboration and License Agreement for Commercialization of Novel Intratumoral Oncolytic Virus Immunotherapies 2020-08-06 23:49
I-Mab to Report Financial Results for the Six Months Ended June 30, 2020 and Provide Corporate Update on August 31, 2020 2020-08-06 20:30
New Rapid Cardiac MR Imaging Helps Detect and Manage Patient Heart Health During and After Cancer Treatments 2020-08-06 00:00
1 194 195 196 197 198 430